Therapeutic Efficacy of Botulinum Toxin (BOTOX®) and Minoxidil in the Treatment of Androgenetic Alopecia in Males
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) · 03.11.2026 · 11 (2) · 245-250
DOI: 10.54133/ajms.v11i2.3376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), online erschienen am 03.11.2026. Verfasst von Marwan Kameran Qader Salihi und 2 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Background
Androgenetic alopecia is hair loss in men. Minoxidil is an established treatment, whereas botulinum toxin is an uncertain therapeutic option.
Objective
To compare the therapeutic efficacy of minoxidil and BOTOX®.
Methods
Our randomized, comparative interventional clinical study included male patients with androgenetic alopecia who were randomly allocated to two treatment groups. Group I received topical 5% minoxidil twice daily, while Group II received botulinum toxin type A. Treatment response was assessed next month using vertex hair density and patient-reported hair-growth improvement.
Results
The clinical and demographic characteristics were comparable in our two groups at baseline. Vertex hair density is comparable at baseline (84.5 vs. 78.5 hairs/cm², p=0.1), at 3 months (84.5 vs. 81 hairs/cm², p=0.3), and at 6 months (90 vs. 86 hairs/cm², p=0.2) in the minoxidil and BOTOX® groups, respectively. Within-group analysis demonstrated a statistically significant increase in hair density over time in the minoxidil group (p=0.007), with no significant change observed in the BOTOX® group (p=0.6). However, the change in hair density and improvement were not very different in our two study groups (p=0.7 and p=0.5, respectively). At month 6, hair growth was significantly favored by minoxidil (p=0.001), with 86.7% reporting some degree of improvement compared with 73.4% in the BOTOX® group.
Conclusions
Topical 5% minoxidil produced a significant improvement in vertex hair density and was associated with greater patient-reported improvement over six months. Botulinum toxin showed less effect.
Zitieren
APA
Salihi, M. K. Q., Al-Ansare, N. J. H., & Malek, A. A. (2026). Therapeutic Efficacy of Botulinum Toxin (BOTOX®) and Minoxidil in the Treatment of Androgenetic Alopecia in Males. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 11(2), 245-250. https://doi.org/10.54133/ajms.v11i2.3376
Vancouver
Salihi MKQ, Al-Ansare NJH, Malek AA. Therapeutic Efficacy of Botulinum Toxin (BOTOX®) and Minoxidil in the Treatment of Androgenetic Alopecia in Males. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 2026;11(2):245-250. doi:10.54133/ajms.v11i2.3376
BibTeX
@article{Salihi2026,
author = {Salihi, Marwan Kameran Qader and Al-Ansare, Noor-Aldeen Jamal Hasan and Malek, Azma Abdul},
title = {Therapeutic Efficacy of Botulinum Toxin (BOTOX®) and Minoxidil in the Treatment of Androgenetic Alopecia in Males},
journal = {Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )},
year = {2026},
volume = {11},
number = {2},
pages = {245--250},
doi = {10.54133/ajms.v11i2.3376}
}
EUVIMED